[{"id":"aecf3ac5-9504-4f3a-9a5f-7cc5aaedb65d","acronym":"NCI-2019-03212","url":"https://clinicaltrials.gov/study/NCT03965689","created_at":"2021-01-18T19:30:37.082Z","updated_at":"2024-07-02T16:35:02.796Z","phase":"Phase 2","brief_title":"Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy","source_id_and_acronym":"NCT03965689 - NCI-2019-03212","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" BRAF • ALK • ROS1 • B2M • RAD51 • CD4 • NQO1 • NTRK • SLC7A11 • UBE2M • ATF3 • NAE1","pipe":" | ","alterations":" BRAF V600E • EGFR mutation • BRAF V600 • ALK mutation • ROS1 positive • SLC7A11 expression","tags":["BRAF • ALK • ROS1 • B2M • RAD51 • CD4 • NQO1 • NTRK • SLC7A11 • UBE2M • ATF3 • NAE1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF V600E • EGFR mutation • BRAF V600 • ALK mutation • ROS1 positive • SLC7A11 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel • pevonedistat (MLN4924)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 27","initiation":"Initiation: 04/16/2020","start_date":" 04/16/2020","primary_txt":" Primary completion: 09/07/2022","primary_completion_date":" 09/07/2022","study_txt":" Completion: 03/20/2025","study_completion_date":" 03/20/2025","last_update_posted":"2024-05-17"},{"id":"c6bc04e2-9101-4684-97ce-c7df5b66b9c5","acronym":"","url":"https://clinicaltrials.gov/study/NCT03268993","created_at":"2021-01-18T16:08:50.337Z","updated_at":"2024-07-02T16:35:51.189Z","phase":"","brief_title":"Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer","source_id_and_acronym":"NCT03268993","lead_sponsor":"University of Pittsburgh","biomarkers":" NQO1","pipe":"","alterations":" ","tags":["NQO1"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 07/27/2018","start_date":" 07/27/2018","primary_txt":" Primary completion: 07/22/2019","primary_completion_date":" 07/22/2019","study_txt":" Completion: 07/22/2019","study_completion_date":" 07/22/2019","last_update_posted":"2023-04-07"},{"id":"cc04deed-b664-477d-9b10-48d568eb2e8d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03182959","created_at":"2021-01-18T15:41:47.425Z","updated_at":"2024-07-02T16:36:28.835Z","phase":"Phase 1","brief_title":"Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer","source_id_and_acronym":"NCT03182959","lead_sponsor":"University of Arizona","biomarkers":" CXCL8 • NQO1","pipe":"","alterations":" ","tags":["CXCL8 • NQO1"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 04/24/2017","start_date":" 04/24/2017","primary_txt":" Primary completion: 01/01/2020","primary_completion_date":" 01/01/2020","study_txt":" Completion: 01/19/2021","study_completion_date":" 01/19/2021","last_update_posted":"2021-06-21"},{"id":"21e923dc-a90c-4e6e-81df-bdbeaee64e4d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01753908","created_at":"2021-01-18T07:42:02.462Z","updated_at":"2024-07-02T16:36:54.100Z","phase":"Phase 1","brief_title":"Broccoli Sprout Extract in Treating Patients With Breast Cancer","source_id_and_acronym":"NCT01753908","lead_sponsor":"Roswell Park Cancer Institute","biomarkers":" ER • CASP3 • NQO1","pipe":" | ","alterations":" ER positive • ER expression","tags":["ER • CASP3 • NQO1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • ER expression"],"overall_status":"Completed","enrollment":" Enrollment 30","initiation":"Initiation: 05/21/2013","start_date":" 05/21/2013","primary_txt":" Primary completion: 07/23/2018","primary_completion_date":" 07/23/2018","study_txt":" Completion: 08/23/2018","study_completion_date":" 08/23/2018","last_update_posted":"2019-10-31"}]